Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Chataway

Showing results (41-50 of 49) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 49 results.
Neurogenetics|May 18, 1999
HLA typing in the United Kingdom multiple sclerosis genome screenF Coraddu, S Sawcer, R Feakes, et al.
Multiple Sclerosis and Related Disorders|September 26, 2020
Patient perspective on decisions to switch disease-modifying treatments in relapsing-remitting multiple sclerosisA Manzano, I Eskyté, H L Ford, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|December 21, 2013
A practical approach to diagnosing adult onset leukodystrophiesR M Ahmed, E Murphy, I Davagnanam, et al.
Journal of Neurology|March 10, 2009
Grey matter magnetization transfer ratio independently correlates with neurological deficit in secondary progressive multiple sclerosisT Hayton, J Furby, K J Smith, et al.
Journal of Neuroimmunology|September 25, 1999
No evidence for association of multiple sclerosis with the complement factors C6 and C7J Chataway, S Sawcer, D Sherman, et al.
AJNR. American Journal of Neuroradiology|November 6, 2020
NAA is a Marker of Disability in Secondary-Progressive MS: A Proton MR Spectroscopic Imaging StudyB S Solanky, N A John, F DeAngelis, et al.
Journal of Neurology|March 7, 2023
Profiling cognitive-motor interference in a large sample of persons with progressive multiple sclerosis and impaired processing speed: results from the CogEx studyR Veldkamp, M D'hooge, B M Sandroff, et al.
Multiple Sclerosis and Related Disorders|August 30, 2024
Associations between fatigue impact and physical and neurobehavioural factors: An exploration in people with progressive multiple sclerosisL Connolly, S Chatfield, J Freeman, et al.
Multiple Sclerosis and Related Disorders|June 4, 2018
Validating the portal population of the United Kingdom Multiple Sclerosis RegisterR M Middleton, W J Rodgers, J Chataway, et al.
Pageof 5

Showing results (41-50 of 49) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 49 results.
Neurogenetics|May 18, 1999
HLA typing in the United Kingdom multiple sclerosis genome screenF Coraddu, S Sawcer, R Feakes, et al.
Multiple Sclerosis and Related Disorders|September 26, 2020
Patient perspective on decisions to switch disease-modifying treatments in relapsing-remitting multiple sclerosisA Manzano, I Eskyté, H L Ford, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|December 21, 2013
A practical approach to diagnosing adult onset leukodystrophiesR M Ahmed, E Murphy, I Davagnanam, et al.
Journal of Neurology|March 10, 2009
Grey matter magnetization transfer ratio independently correlates with neurological deficit in secondary progressive multiple sclerosisT Hayton, J Furby, K J Smith, et al.
Journal of Neuroimmunology|September 25, 1999
No evidence for association of multiple sclerosis with the complement factors C6 and C7J Chataway, S Sawcer, D Sherman, et al.
AJNR. American Journal of Neuroradiology|November 6, 2020
NAA is a Marker of Disability in Secondary-Progressive MS: A Proton MR Spectroscopic Imaging StudyB S Solanky, N A John, F DeAngelis, et al.
Journal of Neurology|March 7, 2023
Profiling cognitive-motor interference in a large sample of persons with progressive multiple sclerosis and impaired processing speed: results from the CogEx studyR Veldkamp, M D'hooge, B M Sandroff, et al.
Multiple Sclerosis and Related Disorders|August 30, 2024
Associations between fatigue impact and physical and neurobehavioural factors: An exploration in people with progressive multiple sclerosisL Connolly, S Chatfield, J Freeman, et al.
Multiple Sclerosis and Related Disorders|June 4, 2018
Validating the portal population of the United Kingdom Multiple Sclerosis RegisterR M Middleton, W J Rodgers, J Chataway, et al.
Pageof 5